Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations. - Lin YT; Tsai XC; Tien FM; Kuo YY; Tseng MH; Liu JH; Ko BS; Cheng CL; Chou SC; Lin ME; Lin CC; Chuang MK; et al. (Blood research, 2026)